Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection
Author:
Affiliation:
1. Department of General Surgery; Qilu Hospital; Shandong University; Jinan China
2. Liver Cancer Institute; Zhongshan Hospital; Fudan University; Shanghai China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12364/fullpdf
Reference40 articles.
1. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group;Farges;Cancer,2011
2. Clinicopathological comparison between intrahepatic cholangiocarcinoma arising in livers positive and negative for hepatitis B or C virus;Wakabayashi;Liver Int,2008
3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study;Welzel;Clin Gastroenterol Hepatol,2007
4. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States;Patel;Hepatology,2001
5. A proposed staging system for intrahepatic cholangiocarcinoma;Nathan;Ann Surg Oncol,2009
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning;BMC Medicine;2024-07-08
2. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment;Journal of Ethnopharmacology;2024-06
3. Impact of sarcopenia on the short-term and long-term outcomes of intrahepatic cholangiocarcinoma undergoing hepatectomy: A multi-center study;European Journal of Surgical Oncology;2024-04
4. Precision therapy for intrahepatic cholangiocarcinoma: A case report on adjuvant treatment in a recurrent patient after surgery and literature review;Oncology Letters;2023-12-13
5. Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma;BMC Cancer;2023-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3